Rigetti Computing (NASDAQ: RGTI) shares surged nearly 70% to just over $27 after a landmark government funding announcement, but the stock has since retreated sharply.
As of July 8, RGTI was hovering around $16.60, well below its post-announcement peak and prompting fresh debate among investors about whether the dip represents opportunity.
The U.S. Commerce Department signed a letter of intent with Rigetti for up to $100 million in funding spread over three years, placing the company among a select group of quantum firms backed by public money.
Being chosen from a competitive field is widely viewed as a validation of Rigetti’s technical progress and its long-term potential in the eyes of federal officials.
However, the letter of intent is non-binding, meaning there is a real possibility the funding never fully materialises, and any equity stake granted to the government would dilute existing shareholders.
On the technical side, Rigetti’s latest system, the Cepheus-1-108Q, features 108 qubits and a single gate fidelity rate of 99.9%, a notable improvement over the 99.5% fidelity achieved by an earlier 84-qubit system just 18 months ago.
That progress sounds impressive, but flipping the number around reveals the challenge: a 99.9% fidelity rate means one error in every 1,000 operations, which is roughly 1,000 times too error-prone for commercially viable quantum computing.
For Rigetti’s systems to deliver meaningful real-world results, experts estimate fidelity needs to reach approximately 99.9999%, a threshold that remains far beyond current capabilities.
Rigetti does carry a reasonably healthy balance sheet, reporting $443.5 million in cash and short-term investments alongside minimal debt, giving the company roughly three years of financial runway at current spending levels.
Cash burn is nonetheless increasing, and that trend is expected to accelerate as research complexity grows and any future move toward manufacturing systems at scale demands additional capital.
Rigetti competes alongside other quantum firms including IonQ and D-Wave Quantum in a race to build systems powerful and reliable enough to solve problems beyond the reach of classical computers, such as drug design and advanced materials development.
The core question for investors is straightforward: if you believe Rigetti will deliver commercially viable quantum computers within an optimistic timeframe, the current stock price near $16 may be justifiable.
For those who expect the timeline to commercial viability to extend well beyond what bulls project, RGTI near $20 may still represent more risk than reward at this stage.
